These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 12804433)

  • 1. Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer.
    Wilcken N; Hornbuckle J; Ghersi D
    Cochrane Database Syst Rev; 2003; 2003(2):CD002747. PubMed ID: 12804433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women.
    Gibson LJ; Dawson C; Lawrence DH; Bliss JM
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003370. PubMed ID: 17253488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single agent versus combination chemotherapy for metastatic breast cancer.
    Carrick S; Parker S; Wilcken N; Ghersi D; Marzo M; Simes J
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003372. PubMed ID: 15846660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taxane containing regimens for metastatic breast cancer.
    Ghersi D; Wilcken N; Simes J; Donoghue E
    Cochrane Database Syst Rev; 2003; (3):CD003366. PubMed ID: 12917963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus).
    Hind D; Wyld L; Beverley CB; Reed MW
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004272. PubMed ID: 16437480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of drug/s to a chemotherapy regimen for metastatic breast cancer.
    Jones D; Ghersi D; Wilcken N
    Cochrane Database Syst Rev; 2006 Jul; (3):CD003368. PubMed ID: 16856005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taxane containing regimens for metastatic breast cancer.
    Ghersi D; Wilcken N; Simes J; Donoghue E
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003366. PubMed ID: 15846659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platinum containing regimens for metastatic breast cancer.
    Carrick S; Ghersi D; Wilcken N; Simes J
    Cochrane Database Syst Rev; 2004; (2):CD003374. PubMed ID: 15106201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platinum containing regimens for metastatic breast cancer.
    Carrick S; Ghersi D; Wilcken N; Simes J
    Cochrane Database Syst Rev; 2004; (3):CD003374. PubMed ID: 15266482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taxane-containing regimens for metastatic breast cancer.
    Ghersi D; Willson ML; Chan MM; Simes J; Donoghue E; Wilcken N
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD003366. PubMed ID: 26058962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumour antibiotic containing regimens for metastatic breast cancer.
    Lord S; Ghersi D; Gattellari M; Wortley S; Wilcken N; Simes J
    Cochrane Database Syst Rev; 2004 Oct; 2004(4):CD003367. PubMed ID: 15495049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination versus sequential single agent chemotherapy for metastatic breast cancer.
    Dear RF; McGeechan K; Jenkins MC; Barratt A; Tattersall MH; Wilcken N
    Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD008792. PubMed ID: 24347031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fulvestrant for hormone-sensitive metastatic breast cancer.
    Lee CI; Goodwin A; Wilcken N
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD011093. PubMed ID: 28043088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of drug/s to a chemotherapy regimen for metastatic breast cancer.
    Butters DJ; Ghersi D; Wilcken N; Kirk SJ; Mallon PT
    Cochrane Database Syst Rev; 2010 Nov; 2010(11):CD003368. PubMed ID: 21069675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.
    Sharma R; Hamilton A; Beith J
    Cochrane Database Syst Rev; 2008 Oct; (4):CD004562. PubMed ID: 18843661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer.
    Wagner AD; Thomssen C; Haerting J; Unverzagt S
    Cochrane Database Syst Rev; 2012 Jul; (7):CD008941. PubMed ID: 22786517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toremifene versus tamoxifen for advanced breast cancer.
    Mao C; Yang ZY; He BF; Liu S; Zhou JH; Luo RC; Chen Q; Tang JL
    Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD008926. PubMed ID: 22786516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single agent versus combination chemotherapy for metastatic breast cancer.
    Carrick S; Parker S; Thornton CE; Ghersi D; Simes J; Wilcken N
    Cochrane Database Syst Rev; 2009 Apr; 2009(2):CD003372. PubMed ID: 19370586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taxanes for adjuvant treatment of early breast cancer.
    Ferguson T; Wilcken N; Vagg R; Ghersi D; Nowak AK
    Cochrane Database Syst Rev; 2007 Oct; (4):CD004421. PubMed ID: 17943815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonates for breast cancer.
    Pavlakis N; Schmidt R; Stockler M
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.